Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
VIPAS39 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DNAJC16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TOP3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTF3C5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HCG18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
C6orf52 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF341 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAA60 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDAC6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PITPNM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC92 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUP188 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RABAC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDLIM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNORD23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on